4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,110.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,820.00p
  • 52 Week Low: 1,095.46p
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 0
  • Market Cap: £172.01m

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £12,406,337
Amy Walker 44,016 £488,578
Maria Del Pilar de la Huerta 6,667 £74,004
Hansjörg Plaggemars 6,667 £74,004
Timothy Paul McCarthy 2,388 £26,507

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,071,073 £56,288,910
DELPHI Unternehmensberatung AG 5,071,073 £56,288,910
M&G Plc 4,627,741 £51,367,925
Elevage Medical Technologies Holdings 4,627,741 £51,367,925
Deutsche Balaton AG 4,432,637 £49,202,271
4bb AG 3,665,242 £40,684,186
2invest AG 2,229,083 £24,742,821
Sparta AG 1,351,718 £15,004,070
Latonba AG 778,891 £8,645,690
Franciscus De Busschere 537,255 £5,963,530

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,110.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,820.00p
52 Week Low 1,095.46p
Volume 0
Shares Issued 15.50m
Market Cap £172.01m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.42% below the market average67.42% below the market average67.42% below the market average67.42% below the market average67.42% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Price Trend
15.29% below the market average15.29% below the market average15.29% below the market average15.29% below the market average15.29% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Income Not Available
Growth
57.33% above the market average57.33% above the market average57.33% above the market average57.33% above the market average57.33% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average

4basebio Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page